Table 1.
Drug | Class | Placebo-controlled | Route of administration | ClinicalTrials.gov identifier |
CC-10004 | Anti-inflammatory | No | Oral | NCT00701311 |
Botulinum toxin A | Anticholinergic | Yes | Intrasphincteric | NCT00464373 |
Botulinum toxin A Lidocaine | Anticholinergic Anesthetic | No | Intraprostatic | NCT00529386 |
Pregabalin | Anticonvulsant | Yes | Oral | NCT00371033 |
Tolterodine Tamsulosin | Antimuscarinic Alpha-blocker | Yes | Oral | NCT00913315 |
Tanezumab | Anti-nerve growth factor | Yes | Intravenous | NCT00826514 |
These drugs are registered in clinical trials that are either active, recruiting, or not yet recruiting.